Stockscreener 앱 받기
2.09
3.97%
0.0799
전일 마감가:
$2.0101
열려 있는:
$2.01
하루 거래량:
89,166
Relative Volume:
0.20
시가총액:
$5.45M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+8.85%
1개월 성능:
+5.03%
6개월 성능:
+15.47%
1년 성능:
+0.00%
1일 변동 폭
$2.00
$2.18
1주일 범위
$1.92
$2.18
52주 변동 폭
$1.41
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
명칭
Vivosim Labs Inc
전화
858-224-1000
주소
11555 SORRENTO VALLEY ROAD, SAN DIEGO
VIVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
2.09 | 5.24M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-12-13 | 개시 | H.C. Wainwright | Buy |
| 2017-11-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | 개시 | Raymond James | Outperform |
| 2015-08-11 | 다운그레이드 | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | 개시 | Jefferies | Buy |
| 2015-06-29 | 개시 | Piper Jaffray | Overweight |
모두보기
Vivosim Labs Inc 주식(VIVS)의 최신 뉴스
Trend Review: Is VivoSim Labs Inc a stock for growth or value investorsJuly 2025 WrapUp & Safe Capital Preservation Plans - baoquankhu1.vn
Aug Swings: Is VivoSim Labs Inc stock forming a triangle pattern2025 Risk Factors & Weekly Stock Breakout Alerts - baoquankhu1.vn
Guidance Update: Is VivoSim Labs Inc stock forming a triangle patternWeekly Risk Report & Stepwise Trade Execution Plans - baoquankhu1.vn
Aug EndMonth: What chart patterns are forming on VivoSim Labs IncJuly 2025 Retail & Capital Efficient Trade Techniques - baoquankhu1.vn
CEO Change: Will VivoSim Labs Inc benefit from AI trendsMarket Weekly Review & Comprehensive Market Scan Reports - baoquankhu1.vn
VivoSim Labs, Inc.Common Stock (NQ: VIVS - FinancialContent
Why VivoSim Labs Inc. stock is favored by pension fundsJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - Улправда
Is VivoSim Labs Inc. (4OR) stock prepared for digital transition2025 Historical Comparison & Fast Entry and Exit Trade Plans - Улправда
How VivoSim Labs Inc. stock compares to market leadersWeekly Profit Summary & High Accuracy Investment Signals - Улправда
Can VivoSim Labs Inc. stock deliver surprise earnings beatJuly 2025 Spike Watch & Smart Allocation Stock Reports - Улправда
EPL Limited Price Holds Above Key Fib LevelShort-Term Trading Alerts & Fast Profit Trading Tips - bollywoodhelpline.com
Is VivoSim Labs Inc. (4OR) stock a top dividend aristocrat candidateRisk Adjusted Returns & Stay Ahead With Daily Market Discussions - Улправда
VivoSim Labs appoints Amar Sethi as chief scientific officer By Investing.com - Investing.com Nigeria
Why VivoSim Labs Inc. stock could outperform in 20252026 world cup usa national team round of 16 playmakers set piece tactics expert forecast statistical analysis - ulpravda.ru
Is VivoSim Labs Inc. stock affected by interest rate hikes2026 world cup usa national team semifinals defensive leaders high defensive line winner prediction preview - Улправда
VIVS Insider Trading - Quiver Quantitative
VivoSim Labs appoints Amar Sethi, M.D., Ph.D. as chief scientific officer - marketscreener.com
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer - The Manila Times
VivoSim Labs appoints Amar Sethi as chief scientific officer - Investing.com
Is VivoSim Labs Inc. stock positioned for long term growth2026 world cup usa national team group stage top scorers high defensive line tactical prediction statistical analysis - ulpravda.ru
Target’s SoHo Store Opens Amid Strategic Expansion Efforts - StocksToTrade
VivoSim Labs (NASDAQ:VIVS) Shares Up 2.6% – Should You Buy? - Defense World
Merger Talk: Why retail investors favor VivoSim Labs Inc. stockMarket Rally & Technical Analysis for Trade Confirmation - Улправда
Why retail investors favor VivoSim Labs Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - Улправда
Earnings Update: Why retail investors favor VivoSim Labs Inc. stockTrade Exit Summary & Low Drawdown Momentum Trade Ideas - Улправда
US Stocks Recap: Why VivoSim Labs Inc. stock could outperform in 2025Day Trade & Verified Technical Trade Signals - Улправда
Amar Akhtar Sethi Net Worth (2025) - GuruFocus
Trade Recap: Will VivoSim Labs Inc. stock benefit from automationGlobal Markets & High Win Rate Trade Tips - ulpravda.ru
Buyback Watch: Is VivoSim Labs Inc. stock attractive after correctionWeekly Market Report & Stepwise Entry/Exit Trade Alerts - Улправда
VivoSim Labs Stockholders Approve Directors and Governance Matters - TipRanks
Is VivoSim Labs Inc. stock undervalued vs historical averagesJuly 2025 Selloffs & Free Growth Oriented Trading Recommendations - Улправда
Will VivoSim Labs Inc. stock benefit from automationPortfolio Value Summary & Verified Entry Point Detection - Улправда
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Can VivoSim Labs Inc. (4OR) stock stage a strong rebound this quarter2025 Risk Factors & Expert Approved Trade Ideas - Newser
How VivoSim Labs Inc. (4OR) stock reacts to monetary easingJuly 2025 Short Interest & Long-Term Growth Plans - Newser
What valuation ratios show for VivoSim Labs Inc. (4OR) stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Can VivoSim Labs Inc. (4OR) stock hit consensus price targetsQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - Newser
Will VivoSim Labs Inc. (4OR) stock beat international competitionQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser
How interest rate cuts could boost VivoSim Labs Inc. stockMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
What consensus target says about VivoSim Labs Inc. (4OR) stockPortfolio Value Report & Verified Chart Pattern Signals - Newser
VivoSim Labs (VIVS) Competitors and Alternatives 2025 - MarketBeat
Will VivoSim Labs Inc. (4OR) stock beat revenue estimatesEarnings Growth Report & Real-Time Volume Analysis - Newser
Will VivoSim Labs Inc. (4OR) stock split increase liquidity - Newser
Vivosim Labs Inc (VIVS) 재무 분석
Vivosim Labs Inc (VIVS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):